FISV Earnings

FISV reported its earnings on 2026-05-05, showcasing a revenue of 5.03B against an estimate of 4.76B, resulting in a 5.61% surprise. The EPS was 1.79, surpassing the expected 1.57 by 14.01%. The stock experienced a -8.8% price change on the earnings day and a -11.67% change over the next five days, reflecting market reactions to the results.

Following FISV's earnings announcement on 2026-05-05, the stock price moved by -8.8% on the day of the release. Over the subsequent five days, it saw a -11.67% change. Historically, FISV's stock price tends to shift by an average of 8.18% in the 10 days leading up to earnings and -1.88% in the 10 days following, providing insight into potential market.

For , analysts estimate FISV's annual revenue to reach , while the EPS is projected at . These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between FISV's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, FISV's stock price typically moves by 8.18% in the 10 days before its earnings and -1.88% in the 10 days after. For the upcoming earnings, analysts expect an EPS of and revenue of .

The earnings call summary and Q&A reveal a generally positive outlook. The company is addressing high attrition with strategic initiatives, and Clover shows promising growth potential. While non-Clover SMB experienced a decline, expectations for slight growth and international expansion are positive. AI initiatives are enhancing value for banking clients, and the competitive landscape remains stable. Despite some nonrecurring revenue headwinds, strategic actions are expected to normalize growth. Overall, the strategic focus on Clover, AI, and market expansion suggests a positive sentiment for the stock.